RAP 0.00% 20.5¢ raptor resources limited

Schedule of activities we are aware of: 1st Qtr 2017 1.ResApp...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 452 Posts.
    lightbulb Created with Sketch. 20
    Schedule of activities we are aware of:
    1st Qtr 2017
    1.ResApp Announces Expanded Research Collaboration with MGH (10Jan)***
    2.Monthly Clinical trials MGH/CCC/TCH updates ( usually 3rd week of month) https://clinicaltrials.gov/ct2/show/NCT02973282?term=Cough and Massachusetts&rank=3
    3.WHO update
    4.Australian Adult/Children trials update
    5.Parallel Submission for FDA, CE, Aust Approvals
    6.more items to be added later if any
    2nd Qtr 2017
    1.Monthly Clinical trials MGH/CCC/TCH updates (continues to July)
    2.Parallel Submission for FDA, CE, Aust Approvals (in progress and complete)

    3.more items to be added later if any
    3rd Qtr 2017
    1.Commercialising
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.